Cargando…
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amy...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807073/ https://www.ncbi.nlm.nih.gov/pubmed/27010959 http://dx.doi.org/10.1371/journal.pone.0152082 |
_version_ | 1782423338827644928 |
---|---|
author | Su, Yi Blazey, Tyler M. Owen, Christopher J. Christensen, Jon J. Friedrichsen, Karl Joseph-Mathurin, Nelly Wang, Qing Hornbeck, Russ C. Ances, Beau M. Snyder, Abraham Z. Cash, Lisa A. Koeppe, Robert A. Klunk, William E. Galasko, Douglas Brickman, Adam M. McDade, Eric Ringman, John M. Thompson, Paul M. Saykin, Andrew J. Ghetti, Bernardino Sperling, Reisa A. Johnson, Keith A. Salloway, Stephen P. Schofield, Peter R. Masters, Colin L. Villemagne, Victor L. Fox, Nick C. Förster, Stefan Chen, Kewei Reiman, Eric M. Xiong, Chengjie Marcus, Daniel S. Weiner, Michael W. Morris, John C. Bateman, Randall J. Benzinger, Tammie L. S. |
author_facet | Su, Yi Blazey, Tyler M. Owen, Christopher J. Christensen, Jon J. Friedrichsen, Karl Joseph-Mathurin, Nelly Wang, Qing Hornbeck, Russ C. Ances, Beau M. Snyder, Abraham Z. Cash, Lisa A. Koeppe, Robert A. Klunk, William E. Galasko, Douglas Brickman, Adam M. McDade, Eric Ringman, John M. Thompson, Paul M. Saykin, Andrew J. Ghetti, Bernardino Sperling, Reisa A. Johnson, Keith A. Salloway, Stephen P. Schofield, Peter R. Masters, Colin L. Villemagne, Victor L. Fox, Nick C. Förster, Stefan Chen, Kewei Reiman, Eric M. Xiong, Chengjie Marcus, Daniel S. Weiner, Michael W. Morris, John C. Bateman, Randall J. Benzinger, Tammie L. S. |
author_sort | Su, Yi |
collection | PubMed |
description | Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amyloid burden using data from the Dominantly Inherited Alzheimer’s Network (DIAN), an autosomal dominant Alzheimer’s disease population. Cross-sectional and longitudinal [(11)C]-Pittsburgh Compound B (PiB) PET imaging data from the DIAN study were analyzed. Four candidate reference regions were investigated for estimation of brain amyloid burden. A regional spread function based technique was also investigated for the correction of partial volume effects. Cerebellar cortex, brain-stem, and white matter regions all had stable tracer retention during the course of disease. Partial volume correction consistently improves sensitivity to group differences and longitudinal changes over time. White matter referencing improved statistical power in the detecting longitudinal changes in relative tracer retention; however, the reason for this improvement is unclear and requires further investigation. Full dynamic acquisition and kinetic modeling improved statistical power although it may add cost and time. Several technical variations to amyloid burden quantification were examined in this study. Partial volume correction emerged as the strategy that most consistently improved statistical power for the detection of both longitudinal changes and across-group differences. For the autosomal dominant Alzheimer’s disease population with PiB imaging, utilizing brainstem as a reference region with partial volume correction may be optimal for current interventional trials. Further investigation of technical issues in quantitative amyloid imaging in different study populations using different amyloid imaging tracers is warranted. |
format | Online Article Text |
id | pubmed-4807073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48070732016-03-25 Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group Su, Yi Blazey, Tyler M. Owen, Christopher J. Christensen, Jon J. Friedrichsen, Karl Joseph-Mathurin, Nelly Wang, Qing Hornbeck, Russ C. Ances, Beau M. Snyder, Abraham Z. Cash, Lisa A. Koeppe, Robert A. Klunk, William E. Galasko, Douglas Brickman, Adam M. McDade, Eric Ringman, John M. Thompson, Paul M. Saykin, Andrew J. Ghetti, Bernardino Sperling, Reisa A. Johnson, Keith A. Salloway, Stephen P. Schofield, Peter R. Masters, Colin L. Villemagne, Victor L. Fox, Nick C. Förster, Stefan Chen, Kewei Reiman, Eric M. Xiong, Chengjie Marcus, Daniel S. Weiner, Michael W. Morris, John C. Bateman, Randall J. Benzinger, Tammie L. S. PLoS One Research Article Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amyloid burden using data from the Dominantly Inherited Alzheimer’s Network (DIAN), an autosomal dominant Alzheimer’s disease population. Cross-sectional and longitudinal [(11)C]-Pittsburgh Compound B (PiB) PET imaging data from the DIAN study were analyzed. Four candidate reference regions were investigated for estimation of brain amyloid burden. A regional spread function based technique was also investigated for the correction of partial volume effects. Cerebellar cortex, brain-stem, and white matter regions all had stable tracer retention during the course of disease. Partial volume correction consistently improves sensitivity to group differences and longitudinal changes over time. White matter referencing improved statistical power in the detecting longitudinal changes in relative tracer retention; however, the reason for this improvement is unclear and requires further investigation. Full dynamic acquisition and kinetic modeling improved statistical power although it may add cost and time. Several technical variations to amyloid burden quantification were examined in this study. Partial volume correction emerged as the strategy that most consistently improved statistical power for the detection of both longitudinal changes and across-group differences. For the autosomal dominant Alzheimer’s disease population with PiB imaging, utilizing brainstem as a reference region with partial volume correction may be optimal for current interventional trials. Further investigation of technical issues in quantitative amyloid imaging in different study populations using different amyloid imaging tracers is warranted. Public Library of Science 2016-03-24 /pmc/articles/PMC4807073/ /pubmed/27010959 http://dx.doi.org/10.1371/journal.pone.0152082 Text en © 2016 Su et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Su, Yi Blazey, Tyler M. Owen, Christopher J. Christensen, Jon J. Friedrichsen, Karl Joseph-Mathurin, Nelly Wang, Qing Hornbeck, Russ C. Ances, Beau M. Snyder, Abraham Z. Cash, Lisa A. Koeppe, Robert A. Klunk, William E. Galasko, Douglas Brickman, Adam M. McDade, Eric Ringman, John M. Thompson, Paul M. Saykin, Andrew J. Ghetti, Bernardino Sperling, Reisa A. Johnson, Keith A. Salloway, Stephen P. Schofield, Peter R. Masters, Colin L. Villemagne, Victor L. Fox, Nick C. Förster, Stefan Chen, Kewei Reiman, Eric M. Xiong, Chengjie Marcus, Daniel S. Weiner, Michael W. Morris, John C. Bateman, Randall J. Benzinger, Tammie L. S. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title_full | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title_fullStr | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title_full_unstemmed | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title_short | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group |
title_sort | quantitative amyloid imaging in autosomal dominant alzheimer’s disease: results from the dian study group |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807073/ https://www.ncbi.nlm.nih.gov/pubmed/27010959 http://dx.doi.org/10.1371/journal.pone.0152082 |
work_keys_str_mv | AT suyi quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT blazeytylerm quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT owenchristopherj quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT christensenjonj quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT friedrichsenkarl quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT josephmathurinnelly quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT wangqing quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT hornbeckrussc quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT ancesbeaum quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT snyderabrahamz quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT cashlisaa quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT koepperoberta quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT klunkwilliame quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT galaskodouglas quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT brickmanadamm quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT mcdadeeric quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT ringmanjohnm quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT thompsonpaulm quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT saykinandrewj quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT ghettibernardino quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT sperlingreisaa quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT johnsonkeitha quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT sallowaystephenp quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT schofieldpeterr quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT masterscolinl quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT villemagnevictorl quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT foxnickc quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT forsterstefan quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT chenkewei quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT reimanericm quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT xiongchengjie quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT marcusdaniels quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT weinermichaelw quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT morrisjohnc quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT batemanrandallj quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT benzingertammiels quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup AT quantitativeamyloidimaginginautosomaldominantalzheimersdiseaseresultsfromthedianstudygroup |